Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ORC

Orchid Island Capital Announces Q3 2025 Results

Orchid Island Capital, Inc. has announced its estimated third-quarter 2025 results, along with the monthly dividend for October 2025 and the RMBS portfolio characteristics as of September 30, 2025.

For the month of October 2025, the company declared a monthly cash dividend of $0.12 per share of common stock, which will be paid on November 26, 2025, to holders of record on October 31, 2025.

The estimated book value per share as of September 30, 2025, was $7.33, and the estimated GAAP net income was $0.53 per share for the quarter ended September 30, 2025, including an estimated $0.37 per share of net realized and unrealized gains on RMBS and derivative instruments.

The estimated total return on equity for the quarter ended September 30, 2025, was 6.6%. The company calculates total return on equity as the sum of dividends declared and paid during the quarter plus changes in book value during the quarter, divided by the company’s stockholders’ equity at the beginning of the quarter.

The company's estimated total stockholders' equity was approximately $1,086.1 million, with 148,239,401 shares of common stock outstanding as of September 30, 2025.

The RMBS portfolio characteristics as of September 30, 2025, are outlined in the press release, including RMBS valuation characteristics, RMBS assets by agency, investment company act of 1940 (whole pool) test results, repurchase agreement exposure by counterparty, and RMBS risk measures.

Orchid Island Capital, Inc. is a specialty finance company that invests on a leveraged basis in agency RMBS. Their investment strategy focuses on traditional pass-through agency RMBS and structured agency RMBS. The company is managed by Bimini Advisors, LLC, a registered investment adviser with the Securities and Exchange Commission. Following these announcements, the company's shares moved 1.11%, and are now trading at a price of $7.27. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS